1215206-15-7

Basic information

• Product Name: 1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine tosylate
• Synonyms: 1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine tosylate
• CAS NO: 1215206-15-7
• Molecular Weight: 599.748
• Mol File: 1215206-15-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine tosylate(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine tosylate(1215206-15-7)
• EPA Substance Registry System: 1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine tosylate(1215206-15-7)

Safety Data

• Hazardous Substances Data: 1215206-15-7(Hazardous Substances Data)

Upstream product

• 104-15-4 toluene-4-sulfonic acid 
• 95635-55-5 Ranolazine 

Relevant articles and documents

NOVEL SOLID STATE FORMS OF RANOLAZINE SALTS

Provided herein are solid state forms of ranolazine salts. Also provided is a stable amorphous form of ranolazine hydrochloride having a water content of less than about 0.5% by weight. Further provided are amorphous co-precipitates of ranolazine or a pharmaceutically acceptable salt thereof with povidone. Processes for the preparation of ranolazine forms, pharmaceutical compositions, and methods of treating thereof are also included. The solid state forms of ranolazine salts are useful for preparing ranolazine in high purity.